Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-01
2005-02-01
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S327000, C514S357000, C514S381000, C514S467000, C514S482000, C514S507000, C514S562000, C514S590000, C544S159000, C546S222000, C546S332000, C548S253000, C549S229000, C560S013000, C560S024000, C560S029000, C560S129000, C560S251000
Reexamination Certificate
active
06849626
ABSTRACT:
The invention relates to semicarbazides of the general formula Iwhere R1, R2, R3, R4and I have the meaning indicated in claim1.The compounds of the formula I can be employed as pharmaceutical active compounds in human and veterinary medicine, in particular for the control and prevention of thromboembolic disorders such as thrombosis, mycocardial infarct, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and intermittent claudication.
REFERENCES:
patent: 3285957 (1966-11-01), Raymond et al.
patent: 1020434 (2000-07-01), None
J.M. Fevig, et al, “Preparation of Meta-amidino-N,N-disubstituted Anilines as Potent Inhibitors of Coagulation Factor Xa,” Bioorganic and Medical Chemistry Letters, Nov. 17, 1998, pp. 3143-3148, vol. 8, no. 22, XP004143716, ISSN: 0960-894X, table 1, Elsevier Science Publishers, Amsterdam, NL.
Barnes Christopher
Dorsch Dieter
Gleiltz Johannes
Juraszyk Horst
Mederski Werner
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Powers Fiona T.
LandOfFree
Aza-amino acid derivatives (factor Xa inhibitors 15) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aza-amino acid derivatives (factor Xa inhibitors 15), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-amino acid derivatives (factor Xa inhibitors 15) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3494369